Heterogeneous expression of Lgr5 as a risk factor for focal invasion and distant metastasis of colorectal carcinoma
Metrics: PDF 478 views | HTML 831 views | ?
Zhong Zheng1,*, Huiping Yu1,*, Qin Huang2, Hongyan Wu1, Yao Fu1, Jiong Shi1, Ting Wang1 and Xiangshan Fan1
1Department of Pathology, The Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, 210000, P.R. China
2Department of Pathology and Laboratory Medicine, Veterans Affairs Boston Healthcare System and Harvard Medical School, Boston, MA, USA
*These authors contributed equally to this work
Xiangshan Fan, email: firstname.lastname@example.org
Keywords: colorectal cancer; Lgr5; heterogeneous expression; progression
Received: April 20, 2017 Accepted: November 14, 2017 Published: July 10, 2018
Leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5) is a downstream target gene of the Wnt/β-catenin signaling pathway and identified as a marker of cancer stem-like cells of colorectal carcinoma (CRC). Here, the heterogeneous expression pattern of Lgr5 and its clinical significance were studied by the method of immunohistochemistry in 204 CRC tumors at various pTNM stages. Lgr5 expression was found in 82.4% (168/204) cases, significantly more common in neoplastic cells at the infiltrative front (n = 59.5%, 110/185) or at the expanding front (n = 36.4%, 59/162) than at the tumor center (n = 16.7%, 34/204; P < 0.01). Tumor budding (TB) was discovered with significantly higher Lgr5 expression (n = 39.3%, 57/145, P = 0.03) and significantly positively correlated between Lgr5 expression and TB grade (r = 0.19, P = 0.02). Additionally, both positive Lgr5 expression and a high TB grade were significantly correlated to the depth of tumor invasion, lymph node metastasis, pTNM stage, and perineural invasion (P < 0.01). The study results suggest that heterogeneous expression of Lgr5 may be a risk factor for local invasion and distant metastasis of CRC.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.